Head and neck symptoms during prolonged simulated weightlessness
8 affiliations
- 1Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, Germany
- 2School of Medicine, Western Sydney University, Sydney, NSW, Australia
- 3Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany
- 4Institute of Sport Science, Leibniz University Hannover, Hannover, Germany
- 5Institute of Aerospace Medicine, German Aerospace Center, Cologne, Germany
- 6Medical Faculty, University of Zurich, Zurich, Switzerland
- 7Medical Faculty, University of Cologne, Cologne, Germany
- 8Department of Anesthesiology and Critical Care Medicine, Cologne-Merheim Medical Center, Witten/Herdecke University, Cologne, Germany
Abstract
Microgravity exposure induces cephalad fluid shifts in astronauts, but systematically collected data on head and neck-related symptoms remain limited and largely anecdotal. We therefore performed a retrospective pooled analysis of nine mid- and long-duration six-degree head-down tilt bed rest campaigns, an established analog of microgravity-induced fluid shifts, conducted at a single research center between 2016 and 2025. Medical records of 101 healthy participants were screened for head and neck-related symptoms before, during and after bed rest. Symptoms were classified and graded using the Common Terminology Criteria for Adverse Events version 6.0, and event frequency, duration, severity and timing were analyzed with phase-specific, exposure-adjusted metrics. A total of 412 head and neck-related events were documented. During head-down tilt, 84 of 101 participants (83.2%) experienced at least one event, compared with 35 participants (34.7%) during the 15-day baseline phase preceding bed rest; overall, 91 participants (90.1%) were affected. Exposure-adjusted event rates were higher during head-down tilt (7.08 events per 100 participant-days) than during the baseline phase (3.56) or the recovery phase (2.04), and this pattern was present in all nine campaigns. Headache and vertigo were the most frequent manifestations, followed by nasal, ocular, otologic and dermatologic symptoms. Onset was analyzed separately for head-down tilt days 1–30, covered by all participants, and days 31–60, covered only by the 60-day campaigns. New events continued to occur during the second month, although at a lower rate than during the first (5.80 versus 8.21 events per 100 participant-days). With the exception of one prolonged tinnitus case, all symptoms had resolved by the end of the recovery phase. Head and neck symptoms were thus common during head-down tilt bed rest, and most events were mild and self-limiting. In the absence of a control group without bed rest, and with heterogeneous countermeasure protocols across campaigns, these descriptive findings do not establish causality. They provide a systematic reference for the design of controlled analog studies of otorhinolaryngological, ocular and dermatological responses to simulated microgravity.
Related
- AI chatbots abandon sleep apnoea referral when simulated patients minimise symptoms
- Adrenal hormones in the maintenance of glucose homeostasis during prolonged fasting in male glucagon‐deficient mice
- Multiple Neurological Complications and Multidrug-Resistant Bacterial Infections During Prolonged Intensive Care for Undocumented Meningoencephalitis in Côte d'Ivoire: A Case Report
- Case Report: Improvement in neurologic symptoms and remission following non-operative management of locally advanced cutaneous squamous cell carcinoma of the head and neck following cemiplimab therapy: two cases
- Foot‐Pedal Monitoring Camera Improves Pedal Operation During Simulated Therapeutic Endoscopy
BibTeX
@article{zimmermann2026head,
title = {{Head and neck symptoms during prolonged simulated weightlessness}},
author = {Philipp H. Zimmermann and Timon Ax and Katharina Garrelfs and Edwin Mulder and Kariem Sharaf and Dipakshi D. Tare and Jens Tank and Jens P. Klussmann and Jens Jordan and Ulrich Limper},
journal = {Frontiers in Physiology},
year = {2026},
month = oct,
doi = {10.3389/fphys.2026.1967313},
url = {https://doi.org/10.3389/fphys.2026.1967313},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Head and neck symptoms during prolonged simulated weightlessness
AU - Philipp H. Zimmermann
AU - Timon Ax
AU - Katharina Garrelfs
AU - Edwin Mulder
AU - Kariem Sharaf
AU - Dipakshi D. Tare
AU - Jens Tank
AU - Jens P. Klussmann
AU - Jens Jordan
AU - Ulrich Limper
PY - 2026
DA - 2026/10/30
JO - Frontiers in Physiology
DO - 10.3389/fphys.2026.1967313
UR - https://doi.org/10.3389/fphys.2026.1967313
AB - Microgravity exposure induces cephalad fluid shifts in astronauts, but systematically collected data on head and neck-related symptoms remain limited and largely anecdotal. We therefore performed a retrospective pooled analysis of nine mid- and long-duration six-degree head-down tilt bed rest campaigns, an established analog of microgravity-induced fluid shifts, conducted at a single research center between 2016 and 2025. Medical records of 101 healthy participants were screened for head and neck-related symptoms before, during and after bed rest. Symptoms were classified and graded using the Common Terminology Criteria for Adverse Events version 6.0, and event frequency, duration, severity and timing were analyzed with phase-specific, exposure-adjusted metrics. A total of 412 head and neck-related events were documented. During head-down tilt, 84 of 101 participants (83.2%) experienced at least one event, compared with 35 participants (34.7%) during the 15-day baseline phase preceding bed rest; overall, 91 participants (90.1%) were affected. Exposure-adjusted event rates were higher during head-down tilt (7.08 events per 100 participant-days) than during the baseline phase (3.56) or the recovery phase (2.04), and this pattern was present in all nine campaigns. Headache and vertigo were the most frequent manifestations, followed by nasal, ocular, otologic and dermatologic symptoms. Onset was analyzed separately for head-down tilt days 1–30, covered by all participants, and days 31–60, covered only by the 60-day campaigns. New events continued to occur during the second month, although at a lower rate than during the first (5.80 versus 8.21 events per 100 participant-days). With the exception of one prolonged tinnitus case, all symptoms had resolved by the end of the recovery phase. Head and neck symptoms were thus common during head-down tilt bed rest, and most events were mild and self-limiting. In the absence of a control group without bed rest, and with heterogeneous countermeasure protocols across campaigns, these descriptive findings do not establish causality. They provide a systematic reference for the design of controlled analog studies of otorhinolaryngological, ocular and dermatological responses to simulated microgravity.
SN - 1664-042X
ER -